Filing Details
- Accession Number:
- 0001144204-11-017343
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-25 19:01:15
- Reporting Period:
- 2011-03-24
- Filing Date:
- 2011-03-25
- Accepted Time:
- 2011-03-25 19:01:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Ave, 20Th Fl New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-03-24 | 28,791 | $4.78 | 351,781 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of a total of 28,791 shares of common stock was made in order to satisfy Mr. Bentsur's income tax withholding obligation upon the vesting of 83,333 shares of restricted stock. Mr. Bentsur had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- Of the 351,781 shares, 191,667 are shares of restricted stock. In addition, Mr. Bentsur holds vested and unvested stock options to purchase up to 798,840 shares of common stock.
Billionaire Hedge Funds
